As a Free StocksGuide user, you can view scores for all 7,042 stocks worldwide.
23 Analysts have issued a Henry Schein forecast:
23 Analysts have issued a Henry Schein forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 12,938 12,938 |
4%
4%
|
|
| Gross Profit | 4,035 4,035 |
2%
2%
|
|
| EBITDA | 1,026 1,026 |
20%
20%
|
|
| EBIT (Operating Income) EBIT | 769 769 |
26%
26%
|
|
| Net Profit | 391 391 |
25%
25%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The Technology & Value-Added Services segment offers financial services on a non-recourse basis, e-services practice, technology, network and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
| Head office | United States |
| CEO | Stanley Bergman |
| Employees | 25,000 |
| Founded | 1932 |
| Website | www.henryschein.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


